Research progress on partial splenic embolization combined with TACE in treatment of primary hepatocellular carcinoma with hypersplenism

doi:10.3877/cma.j.issn.2095-5782.2018.02.009

Abstract

Abstract:

Hypersplenism is a serious complication of portal hypertension in liver cirrhosis, which is a difficult problem for the treatment of this kind of patients. Partial splenic embolization (PSE) is safe, effective, reproducible, minimally invasive, and able to retain partial immune function of spleen in the treatment of hypersplenism. Transcatheter arterial chemoembolization (TACE) has played a pivotal role in the treatment of hepatocellular carcinoma with hypersplenism. The mechanism of primary hepatocellular carcinoma and hypersplenism, partial splenic embolization, operation method and postoperative complications were reviewed.

Key words: Primary hepatocellular carcinoma, Hypersplenism, Transcatheter arterial chemoem-bolization, Partial spleen embolization

Libo Zhang, Zhizhong Ren, Ying Liu, Yuewei Zhang. Research progress on partial splenic embolization combined with TACE in treatment of primary hepatocellular carcinoma with hypersplenism[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2018, 06(02): 133-136.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjrfsxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-5782.2018.02.009

https://zhjrfsxdzzz.cma-cmc.com.cn/EN/Y2018/V06/I02/133

References 25

[1]	Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of Cancer in 2008 GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12):2893-2917.
[2]	Tsochatzis EA, Fatourou E, O'Beirne J, et al. Transarterial chemoembolization and bland embolization for hepatocellullar carcinoma[J]. World J Gastroenterol, 2014, 20(12):3069-3077.
[3]	杨业发，程红岩，徐爱民，等.TACE联合LPSE治疗原发性肝癌伴脾亢的临床研究[J].中华肝胆外科杂志，2003，9(3):150-153.
[4]	Abdella HM, Abd-El-Moez AT, Abu El-Maaty ME, et al. Role of partial splenic arterial embolization for hypersplenism in patients with liver cirrhosis and thrombocytopenia[J]. Indian J Gastroenterol, 2010, 29(2):59-61.
[5]	Alzen G, Basedow J, Luedemann M, et al. Partial splenic embolization as an alternative to splenectomy in hypersplenism-single center experience in 16 years[J]. Klin Padiatr, 2010, 222(6):368-373.
[6]	Maddison FE. Embolic therapy of hypersplenism[J]. Invest Radiol, 1973, 8(4):280-281.
[7]	Wirth TC. Spontaneous and therapeutic immune responses in hepatocellular carcinoma: implications for current and future immunotherapies[J]. Expert Rev Gastroenterol Hepatol, 2014, 8(1):101-110.
[8]	王素，胡继红，赵卫.部分脾栓塞术治疗肝硬化脾功能亢进的进展[J].介入放射学杂志，2014，23(6):546-549.
[9]	欧阳强，肖湘生，董伟华，等.部分性脾栓塞治疗肝癌患者脾功能亢进的疗效观察[J].介入放射学杂志，2003，12(4):273-275.
[10]	章万勇，查云飞.TACE联合部分脾栓塞术对肝癌患者免疫功能影响研究[J].临床放射学杂志，2015，34(3):451-454.
[11]	Hanafiah M, Shahizon AM, Low SF, et al. Severe thrombocytopenia due to hypersplenism treated with partial splenic embolisation[J]. BMJ Case Rep, 2013, 2013: bcr2013010163.
[12]	Elmonem SA, Tantawy HI, Ragheb AS, et al. The outcome of partial splenic embolization for hypersplenism in the cirrhotic patients[J]. The Egyptian Journal of Radiology and Nuclear Medicine, 2011, 42:35-42.
[13]	Jin GY, Lv CZ, Tang D, et al. Effect of partial splenic embolization on the immune function of cirrhosis patients with hypersplenism[J]. Asian Pac J Trop Med, 2016, 9(7): 702-706.
[14]	He XH, Gu JJ, Li WT, et al. Comparison of total splenic artery embolization and partial splenic embolization for hypersplenism[J]. World J Gastroenterol, 2012, 18(24):3138-3144.
[15]	惠本军，张庆桥，陈东民，等.经导管动脉化疗栓塞术联合部分性脾动脉　栓塞术治疗原发性肝癌合并脾功能亢进[J].中国介入影像与治疗学，2012，9(4):262-265.
[16]	Masada T, Tanaka T, Sakaguchi H, et al. Coils versus gelatin particles with or without intraarterial antibiotics for partial splenic embolization：a comparative evaluation[J]. J Vasc Interv Radiol, 2014, 25(6):852-858.
[17]	Matsuoka S, Kamimura S, Mizutani T, et al. Hypersplenism treated by partial splenic embolization using guglielmi detachable coils[J]. Intern Med, 2015, 54(17): 2179-2183.
[18]	Gu JJ, He XH, Li WT, et al. Safety and efficacy of splenic artery coil embolization for hypersplenism in liver cirrhosis[J]. Acta Radiol, 2012, 53(8):862-867.
[19]	Alzen G, Basedow J, Luedemann M, et al. Partial splenic embolization as an alternative to splenectomy in hypersplenism—single center experience in 16 years[J]. Klin Padiatr, 2010, 222(6):368-373.
[20]	Hadduck TA, McWilliams JP. Partial splenic artery embolization in cirrhotic patients[J]. World J Radiol, 2014, 6(5):160-168.
[21]	Smith M, Ray CE. Splenic artery embolization as an adjunctive procedure for portal hypertension[J]. Semin Intervent Radiol, 2012, 29(2):135-139.
[22]	Khurana A, Abdel Khalek M, Brown J, et al. Acute necrotizing pancreatitis following splenic artery embolization[J]. Trop Gastroenterol, 2011, 32(3):226-229.
[23]	Omer S, Zara O, Iacobescu C, et al. Partial splenic embolization for hypersplenism in cirrhotic patients. A case series[J]. J Gastrointestin Liver Dis, 2014, 23(2):215-218.
[24]	Abdella HM, Abd-El-Moez AT, Abu El-Maaty ME, et al. Role of partial splenic arterial embolization for hypersplenism in patients with liver cirrhosis and thrombocytopenia[J]. Indian J Gastroenterol, 2010, 29(2):59-61.
[25]	Ishikawa T, Kubota T, Horigome R, et al. Concurrent partial splenic embolization with transcatheter arterial chemoembolization for hepatocellular carcinoma can maintain hepatic functional reserve[J]. Hepatol Res, 2014, 44(11):1056-1061.

Please choose a citation manager

Content to export